Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-22-059053

10% owner acquired 7,176 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2022-11-29 Option exercise −3,539 $0.00 $0 2,284,612 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2022-11-29 Option exercise −1,723 $0.00 $0 1,121,045 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2022-11-29 Option exercise −1,914 $0.00 $0 1,226,412 I
Derivatives
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2022-11-29 Option exercise · Call Options (obligation to sell) −3,539 0 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2022-11-29 Option exercise · Call Options (obligation to sell) −1,723 0 I
Pontifax Management 4 G.P. (2015) Ltd. 10% owner 2022-11-29 Option exercise · Call Options (obligation to sell) −1,914 0 I
Loading xslF345X03/doc4.xml…